CrushSCI.com
Journal Selection & Manuscript Polishing Services
CURRENT PROBLEMS IN CANCER journal cover Medicine
Back to journal directory

Review Cycle Records

CURRENT PROBLEMS IN CANCER

Elsevier SCIE Non-OA
2026 Emerging Zone 32025 CAS Zone 42025 JCR Q3
123.2Average days
112Median days
28Fastest days
238Longest days
582025 publications

Paper Review Records

All Paper Review Records

10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

81 days

Predictors of change in cognitive function for patients with cancer treated with allogeneic hematopoietic cell transplant

AuthorsMegha Jacob; Matthew A. Bergens; Matthew Braun; Ernaya J. Johnson; Yan Li; Amy T. Bush; Lauren Hill; Sanghee Hong; Patrick Smith; Anthony D. Sung; Jamie S. Myers

AffiliationsDivision of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, 2650 Shawnee Mission Parkway, Westwood, KS, 66205, USA; Department of Emergency Medicine, Duke University School of Medicine, 2301 Erwin Rd, Durham, NC, 27710, USA; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, 2400 Pratt St, Durham, NC, 277705-3976, USA; Duke Cancer Institute Biostatistics Shared Resource, Duke University School of Medicine, Hock Plaza, 8th floor, 2424 Erwin Rd., Durham, NC, 27710, USA; Departments of Psychiatry and Neurology, University of North Carolina at Chapel Hill, 101 Manning Dr., Chapel Hill, NC, 27514, USA; School of Nursing, University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, KS, 66160, USA

Source PDF DOI Publisher page
204 days

Spatial transcriptomics of primary and metastatic ALK-rearranged NSCLC reveals site-specific adaptations

AuthorsWarisa Khatoon; Kaustar Yadav; Amit Katiyar; Sunil Kumar; Sudheer Arava; Anant Mohan; Rambha Pandey; Chandrashekhara SH; Aruna Nambirajan; Prabhat Singh Malik; Deepali Jain

AffiliationsDepartment of Pathology, All India Institute of Medical Sciences, New Delhi, India; Centralized Core Research Facility, All India Institute of Medical Sciences, New Delhi, India; Department of Surgical Oncology, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India; Department of Pulmonary, Critical Care & Sleep Medicine, All India Institute of Medical Sciences, New Delhi, India; Department of Radiation Oncology, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India; Department of Radiodiagnosis, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India; Department of Medical Oncology, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India

Source PDF DOI Publisher page
32 days

Experience of the implementation of a lung cancer screening program at the Hospital General de Catalunya (Barcelona, Spain)

AuthorsIrene Moya-Horno; Adrián González-Marrón; Paula Barcos-Muñoz; Santiago Abad; Miguel Ángel Molina-Vila; Antoni Torres-Martí; Xavier González; Núria Mayolas; Rafael Rosell

AffiliationsMedical Oncology, Hospital Universitari General de Catalunya, Instituto Oncológico Dr Rosell, Pangaea Oncology, Sant Cugat del Vallès, Spain; Department of Medicine, School of Medicine and Health Sciences, Universitat Internacional de Catalunya, Sant Cugat del Vallès, Barcelona, Spain; Pulmonology, Hospital Universitari General de Catalunya, Instituto Oncológico Dr Rosell, Pangaea Oncology, Sant Cugat del Vallès, Spain; Laboratory, Hospital Universitari Quirón Dexeus, Instituto Oncológico Dr Rosell, Pangaea Oncology, Barcelona, Spain; Radiology, Hospital Universitari General de Catalunya, Sant Cugat del Vallès, Spain; Medical Oncology, Hospital Universitari Quirón Dexeus, Instituto Oncológico Dr Rosell, Pangaea Oncology, Barcelona, Spain; Instituto de Investigación Germans Trias i Pujol, Badalona, Spain

Source PDF DOI Publisher page
238 days

Clinicopathological profile and treatment outcomes of advanced/unresectable thymic malignancies from a tertiary care centre in India

AuthorsSwasthik Upadhya; Jayashimman Vasanthraman; Aparna Sharma; Sachin Khurana; Deepam Pushpam; Mukesh Kumar; Sanjay Thulkar; Deepali Jain; Aruna Nambirajan; Sunil Kumar; Sushmita Pathy; Prabhat Singh Malik

AffiliationsDepartment of Medical Oncology, Father Muller Medical College, Mangalore, Karnataka, 575002, India; All India Institute of Medical Sciences, New Delhi, 110029, India; Department of Medical Oncology, National Cancer Institute - All India Institute of Medical Sciences, Jhajjar, Haryana, 124105, India; Department of Medical Oncology, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, 110029, India; Department of Radiodiagnosis, All India Institute of Medical Sciences, New Delhi, 110029, India; Department of Pathology, All India Institute of Medical Sciences, New Delhi, 110029, India; Department of Surgical Oncology, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, 110029, India; Department of Radiation Oncology, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, 110029, India

Source PDF DOI Publisher page
211 days

Multicenter retrospective study on the clinical profiles of patients with extensive-stage small-cell lung cancer who met the eligibility criteria for clinical trials

AuthorsTatsuya Yazaki; Kei Sonehara; Toshiharu Tsutsui; Shuhei Nozawa; Toshihiko Agatsuma; Manabu Yamamoto; Akemi Matsuo; Masanori Nakanishi; Tomoshige Chiaki; Akane Kato; Takashige Miyahara; Tsutomu Hachiya; Shintaro Kanda; Masayuki Hanaoka

AffiliationsDepartment of Respiratory Medicine, Minaminagano Medical Center, Shinonoi General Hospital, 666-1, Shinonoiai, Nagano, 388-8004, Japan; First Department of Internal Medicine, Shinshu University School of Medicine, 3-1-1, Asahi, Matsumoto, Nagano, 390-8621, Japan; Department of Respiratory Medicine, Yamanashi Prefectural Central Hospital, 1-1-1, Fujimi, Kofu, Yamanashi, 400-8506, Japan; Department of Respiratory Medicine, Nagano Municipal Hospital, 1333-1, Tomitake, Nagano, 381-8551, Japan; Department of Respiratory Medicine, National Hospital Organization Shinshu Ueda Medical Center, 1-27-21, Midorigaoka, Ueda, Nagano, 386-8610, Japan; Department of Respiratory Medicine, Nagano Red Cross Hospital, Nagano City, 380-0928, Japan; Department of Respiratory Medicine, Aizawa Hospital, 2-5-1, Honjo, Matsumoto, Nagano, 390-0814, Japan; Department of Respiratory Medicine, Hokushin General Hospital, 1-5-63, Nishi, Nakano, Nagano, 383-0021, Japan; Department of Respiratory Medicine, Ina Central Hospital, 1313-1, Koshiroukubo, Ina, Nagano, 396-8555, Japan; Department of Respiratory Medicine, Nagano Matsushiro General Hospital, 183, Matsushiro, Nagano, 381-1231, Japan; Department of Respiratory Medicine, Japanese Red Cross Suwa Hospital, 5-11-50, Kogandori, Suwa, Nagano, 392-0027, Japan; Department of Hematology/Oncology Medicine, Shinshu University School of Medicine, 3-1-1, Asahi, Matsumoto, Nagano, 390-8621, Japan

Source PDF DOI Publisher page
28 days

Genomic risk distribution, adjuvant chemotherapy trends, and survival outcomes in women with pT1, grade 1-2, ER/PR-positive, LVI-negative breast cancer

AuthorsNickolas Stabellini; Maya Lubarsky; Ananya Munjal; Amanda L. Amin; Megan E. Miller; Alberto J. Montero

AffiliationsCase Western Reserve University School of Medicine, Case Western Reserve University, Cleveland, OH, United States; Immunomonitoring Laboratory, Center for Immunotherapy & Precision Immuno-Oncology, Cleveland Clinic, Cleveland, OH, United States; Division of Hematology and Oncology, Department of Medicine, University Hospitals Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH, United States; Department of Internal Medicine, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, United States; University Hospitals Research in Surgical Outcomes and Effectiveness (UH-RISES), University Hospitals Cleveland Medical Center, Cleveland, OH, United States; Division of Surgical Oncology, Department of Surgery, University Hospitals Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH, United States

Source PDF DOI Publisher page
43 days

Predictors of pathological upgrading in low-risk gleason grade group 1 prostate cancer on prostate biopsy: the role of clinical and tumor-specific factors

AuthorsShirin Razdan; Ali Fathollahi; Alexandre Armache; Sanjay Razdan

AffiliationsMiami Robotic Surgery, Miami, FL, USA; Palmetto General Hospital, Miami, FL, USA; International Robotic Institute for Prostate Cancer, Miami, FL, USA

Source PDF DOI Publisher page
203 days

Patterns of care for older multiple myeloma patients in the U.S.: An analysis of the national cancer database

AuthorsMuni Rubens; Jeremy Purow; Daniel M. Portnoy; Alejandra Viera Plasencia; Julia Steger; Sofia Steger; Feng Go Ho Wu; Jorge Valdés; Vicente Andreu Fernández; Vicente Gea Caballero; Sandra Sepúlveda; Paolo Cháves; Marco A Ruiz Andia

AffiliationsBaptist Health, Department of Internal Medicine, Miami, FL, USA; Florida International University Herbert Wertheim College of Medicine, Miami, FL, USA; Baptist Health Miami Cancer Institute, Miami, FL, USA; Valencia International University, Valencia, Spain; Florida International University Department of Molecular Medicine, Miami, FL, USA

Source PDF DOI Publisher page
49 days

Too late to fall: Time to PSA nadir and early oncologic failure after cryotherapy and high-intensity focused ultrasound for localized prostate cancer

AuthorsUmberto Anceschi; Salvatore Basile; Leonardo Misuraca; Riccardo Mastroianni; Rocco Simone Flammia; Simone D’Annunzio; Alfredo Maria Bove; Riccardo Capecchi; Flavia Proietti; Francesco Prata; Mariaconsiglia Ferriero; Lorenzo Capecchi; Franco Lugnani; Giuseppe Simone

AffiliationsUro-Oncology Program, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144 Rome, Italy

Source PDF DOI Publisher page
143 days

Advancements and perspectives of neoadjuvant immunotherapy in resectable non-small cell lung cancer

AuthorsAparna Sharma; Praful Pandey; Swasthik Upadhya; Deepam Pushpam; Sachin Khurana; Garima Devi; Sunil Kumar; Deepali Jain; C.S. Pramesh; Sabita Jiwnani; Prashant Tembhare; Subir Biswas; Haydn Kissick; Tahseen Nasti; Rafi Ahmad; Suresh S Ramalingam; Nikhil Singla; Prabhat Singh Malik

AffiliationsDepartment of Medical Oncology, National Cancer Institute, Jhajjar campus, All India Institute of Medical Sciences, New Delhi, India; Department of Medical oncology, Dr. B.R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India; Department of Medical Oncology, Father Muller Medical College, Mangalore, Karnataka, India; Department of Surgical Oncology, Dr. B.R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India; Department of Pathology, All India Institute of Medical Sciences, New Delhi, India; Department of Surgical Oncology, Tata Memorial Centre, Mumbai, India; Department of Hematopathology, ACTREC, Tata Memorial Centre, HBNI, Navi Mumbai, India; Department of tumor Immunology and Immunotherapy, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Kharghar, Navi Mumbai, India; Department of Urology, Emory University, Atlanta, GA, USA; Department of Immunology and Microbiology, Emory University, Atlanta, GA, USA; Winship Cancer Institute, Emory University, Atlanta, GA, USA; Emory India Research and Education Innovation LLP, Emory University, Atlanta, GA, USA

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.